Site map

• About us
  • Careers
  • Environmental, social and governance strategy
  • Executive team
  • Health regulations and standards
  • Meet our experts
  • Our locations
  • Partnerships
    • Biopharma
    • NHS
    • Working with healthcare professionals
  • Patient care and safety
• Annual duty of candour report – Scotland
• Business customers and prospective Partners privacy notice
• Contact us
• Cookie notice
• Driver vehicle monitoring & dashcam privacy notice
• Employee and contractors privacy notice
  • How long we keep your information for
  • How we keep your information safe
  • How we use your information
  • Where we get your information from
  • Who we will share your information with
  • Your rights
• Get in touch
• Google analytics notice
• Knowledge base
• Meet us at the UK Oncology Forum 2024
• Meet us at the World Orphan Drug Congress 2024
• NHS biosimilar switching
• Patient hub
  • How we help
    • For cancer patients
      • Private patients
      • Sciensus cancer care nurses
    • Sciensus Companion app
    • Sciensus Intouch app
  • New patients: where to start and what to expect
  • NHS patients
  • NHS updates privacy notice
  • Patient enquiry
  • Patient privacy notice
    • How long we keep your information for
    • How we use your information
    • Live Chat
    • Where we get your information from
    • Who we will share your information with
    • Your rights
  • Patient Resources
• Practising privileges privacy notice
• Privacy notices
  • How we keep your information safe
• Privacy notices
• Privately funded patient terms and conditions
• Recruitment and selection privacy notice
  • For what purpose do we collect your personal information?
  • How long do we keep your information?
  • How we keep your information safe
  • What information do we collect from you?
  • Where we get your information from
  • Why do we collect this information and who do we share it with?
  • Your rights
• Sciensus – rare disease services privacy notices
  • Algemene informatieve mededeling voor de verwerking van persoonsgegevens in het kader van de patiëntendiensten van Sciensus BV
  • Allgemeine Informationen zur Verarbeitung personenbezogener Daten im Rahmen der Patientendienste von Sciensus BV
  • Fortrolighedsmeddelelse for EU Rare Sciensus BV støtteprogram og studie
  • Generell informasjonsmelding for behandling av personopplysninger innenfor rammen av Sciensus BV pasienttjenester
  • Notice générale d’information pour le traitement des données à caractère personnel dans le cadre des services patients de Sciensus BV
  • Sciensus BV Support Programme and Study Privacy Notice
• Sciensus analytics notice
• Sciensus Companion and SciensusPRO Privacy Notice
• Sciensus Digital+
• Sciensus Intouch app privacy notice
• Sciensus Intouch terms of use
• Sciensus patient and carer representative
• Sciensus Portal user privacy notice
• Sciensus set to address patient support challenges in Europe at World Orphan Drug Congress 2024
• Services
  • Aseptic compounding
  • Blood monitoring services
  • Clinical homecare
  • Clinical screening services
  • Clinical trials
  • Digital tools
    • Healthcare products (via Sciensus Axcess)
    • Online communities
    • Sciensus Connect
    • SciensusPRO
  • Dispense and delivery
  • E-prescription services
  • Early access programmes
  • Non-medical prescribing services
  • Nursing and clinical services
  • Patient support programmes
  • Pharmaceutical market access consulting services
  • Pharmaceutical storage and distribution
  • Pharmacovigilance services
  • Real-world data
  • Regulatory approval consulting
  • Supply chain management
  • Switching services
  • Virtual Wards
• Switzerland
  • Careers
  • Pharmacy
  • Privacy notices menu
    • Privacy notices
      • Employee and contractors privacy notice
      • Recruitment and selection privacy notice
  • Spitex
  • Wholesale
• Tax strategy
• Technology and innovation
• Terms and conditions
  • Accessibility statement
• Terms and conditions menu
• Therapeutic areas
  • Cancer
  • Chronic conditions
  • Rare diseases and orphan drugs
    • European drug approval pathway
    • Finding patients: Tailored strategies for better outcomes 
    • Orphan drugs supply chain management
  • Reaching European cancer patients – faster  
• WODC 2025